Article
The regulation effect of GLUT9/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease.
Hepatology international - 1 Oct 2022
Zeng Hang, Tang Chenxi, Lin Bingru, Yu Mengli, Wang Xinyu, Wang Jinghua, Chen Shenghui, Yu Chaohui
Abstract excerpt
BACKGROUND: Metabolic associated fatty liver disease (MAFLD) is the most common chronic liver disease worldwide. The important role of urid acid (UA) in MAFLD has been widely investigated. Our previous studies unveiled the elevation of serum UA levels independently predicts an increased risk of incident MAFLD. However, the role of intrahepatic UA in MAFLD has not been investigated yet. Glucose transporter 9...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
